PUBLIC CONTRACT · 2023
050104042023-Idursulfase 2 mg/ml sol inj fr 3 ml IV
- Contract value
- €30,152.52
- Signed on
- 13 December 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10898481PUBLISHED SUBJECT
050104042023-IDURSULFASE 2 MG/ML SOL INJ FR 3 ML IV
Parties involved
- Place of performance
- Portugal, Coimbra, Coimbra
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Takeda - Farmacêuticos Portugal, Lda. · Tax ID 502801204
Values and timeline
- Contract price
- €30,152.52
- Procedure base price
- €30,152.52
- Total effective price
- Not reported on Portal BASE
- Publication date
- 3 September 2024
- Award date
- 13 December 2023
- Signing date
- 13 December 2023
- Performance period
- 34 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2022/58 - Acordo-quadro para fornecimento de medicamentos para doenças lisossomais de sobrecarga, na área da saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6823940
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.